Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide)
December 6, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)
November 25, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
Upsher-Smith Laboratories, LLC Selects PANTHERx® Rare for the Distribution of TORPENZ™ (everolimus) Tablets
August 20, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the...
Read More
PANTHERx® Rare Partnering with Gilead Sciences, Inc. for the Distribution of LIVDELZI®
August 16, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Partnering with ITF Therapeutics LLC for U.S. Distribution of DUVYZAT™
July 30, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United...
Read More
PANTHERx® Rare Appoints Bansi Nagji as CEO; Rob Snyder appointed Executive Chair
July 25, 2024 PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies,...
Read More
